MyFinsight
Home
Blog
About
Contact
Download
Download image
ASCENIV
$97,486K
BIVIGAM
$15,422K
Intermediates And Other
$833K
ADMABio Manufacturing
Segment
$113,741K
Plasma Collection
Centers Segment
$716K
Material Reconciling
Items
$36K
(0.00%↑ Y/Y)
Revenues
$114,493K
(-0.27%↓ Y/Y)
Gross profit
$80,750K
(32.17%↑ Y/Y)
Cost of product
revenue
$33,743K
(-37.17%↓ Y/Y)
Income from operations
$58,274K
(67.07%↑ Y/Y)
Total operating
expenses
$22,476K
(-14.27%↓ Y/Y)
Gain on sale of plasma
centers
$7,980K
Income before income
taxes
$57,127K
(70.78%↑ Y/Y)
Other income
(expense), net
-$1,147K
(19.85%↑ Y/Y)
Interest and other income
$1,093K
Selling, general and
administrative
$26,742K
(11.06%↑ Y/Y)
Research and development
$2,597K
(214.41%↑ Y/Y)
Plasma center
operating expenses
$1,062K
(-17.42%↓ Y/Y)
Amortization of intangible
assets
$55K
(120.00%↑ Y/Y)
Net income
$45,328K
(68.48%↑ Y/Y)
Provision for income taxes
$11,799K
(80.25%↑ Y/Y)
Interest expense
$2,100K
(6.33%↑ Y/Y)
Other expense
-$140K
(-118.75%↓ Y/Y)
Back
Back
Income Statement
ADMA BIOLOGICS, INC. (ADMA)
ADMA BIOLOGICS, INC. (ADMA)
source: myfinsight.com